Liquent, Inc., a Horsham, PA-based provider of software and service solutions designed to support the regulatory business processes of life sciences companies, has been acquired by private investment firm Marlin Equity Partners from Thomson Reuters.
Liquent’s current General Manager, Rick Riegel, who will continue his leadership position as the CEO of the company, said: “Marlin brings substantial financial resources and expertise in the healthcare IT sector.
“With their backing and Liquent’s comprehensive software and service solutions, industry leadership, and focus on customer service, we look forward to accelerating our growth and ability to service the evolving and rapidly changing needs of the life sciences industry”, Riegel added.
Liquent regulatory solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.
FinSMEs
07/01/2010